Search Within

Brian Kushner

Formats
  1. Journal Article (181)
  2. Meeting Abstract (113)
  3. Conference Paper (9)
  4. Book Section (4)
  5. Editorial (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Neuroblastoma Service (311)
  2. Pediatrics, Department of (311)
  3. GSK Faculty (233)
  4. Tow Center for Developmental Oncology (TCDO) (233)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (230)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (227)

More Groups

People
  1. Nai-Kong Cheung (227)
  2. Shakeel Modak (154)
  3. Kim Kramer (132)
  4. Michael La Quaglia (80)
  5. Ellen Basu (68)
  6. Stephen Roberts (63)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (14)

More Years

Publications
  1. Pediatric Blood and Cancer (65)
  2. Journal of Clinical Oncology (60)
  3. International Journal of Radiation Oncology, Biology, Physics (26)
  4. Cancer (19)
  5. Medical and Pediatric Oncology (10)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. Wiley Periodicals, Inc (65)
  2. American Society of Clinical Oncology (61)
  3. Elsevier Inc. (33)
  4. Wiley Blackwell (19)
  5. American Association for Cancer Research (14)
  6. Oxford University Press (14)

More Publishers

Results (311)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
    Journal Article

    Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Impact of disease site, size and surgical resection on survival from metastatic CNS neuroblastoma
    Meeting Abstract

    Kramer, K.; Haque, S.; Wolden, S.; Greenfield, J.; Kushner, B.; Modak, S.; Cheung, N. K.; Donzelli, M.; Eljalby, M.; Souweidane, M.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial
    Journal Article

    Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Short hypofractionated radiation therapy in palliation of pediatric malignancies: Outcomes and toxicities
    Meeting Abstract

    Lazarev, S.; Kushner, B.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save